© Copyright 2026 American Medical Association. All rights reserved.
Radiopharmaceutical localization of inflammatory processes using CPT® Code 78807 involves the application of single photon emission computed tomography (SPECT) in conjunction with a radiolabeled isotope tracer. This advanced imaging technique is specifically designed to identify and localize areas of inflammation within the body. The radiolabeled isotope tracer is engineered to bind selectively to inflammatory cells, allowing for precise targeting of regions affected by inflammation or infection, whether acute or chronic. The procedure begins with the establishment of an intravenous line through which the radiolabeled tracer is administered directly into the patient's circulatory system. Alternatively, a blood sample may be drawn, and the white blood cells are separated via centrifugation, tagged with the isotope tracer, and subsequently reintroduced into the patient. Once the tracer is in circulation, it migrates to sites of inflammation, enabling visualization. During the imaging process, the patient is positioned on an imaging table while one or more gamma cameras rotate around the body, capturing a three-dimensional view of the targeted area. The emitted radioactive energy is then converted into detailed images, which are processed and displayed in tomographic sections or as a cinematic sequence. The physician interprets these images and compiles a comprehensive written report detailing the findings of the study, which is crucial for further clinical decision-making.
© Copyright 2026 Coding Ahead. All rights reserved.
Get instant expert-level answers from CasePilot, our coding assistant.
Create a free account to unlock this content
Create a free account to unlock this content
Create a free account to unlock this content
Create a free account to unlock this content
Create a free account to unlock this content
Get instant expert-level medical coding assistance.